Emerging Trends to Reshape the Cardiac Valve Market: Transforming Cardiac Care With Technological Advancements In The Cardiac Valve Market as a Key Influencer

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Cardiac Valve Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for cardiac valves has seen significant expansion in recent times. Its growth trajectory projects an increase from $10.89 billion in 2024 to $12.41 billion in 2025, marking a compound annual growth rate (CAGR) of 13.9%. Factors contributing to the growth during the historical period include the aging population and the consequential rise in valvular heart diseases, an increased incidence of risk factors such as obesity and hypertension, advancements in diagnostic and imaging technologies for valve ailments, public awareness initiatives and education about heart health and valve diseases, and the emergence of minimally invasive and transcatheter valve procedures.

Cardiac Valve Market Size Forecast: What's the Projected Valuation by 2029?
In the coming years, the market for cardiac valves is predicted to experience fast growth, soaring to a value of $21.22 billion by 2029 with a compound annual growth rate (CAGR) of 14.4%. This projected growth within the forecast period can be associated with factors such as rising demand for bioengineered and tissue-engineered heart valves, the aging global community, and the growing need for treatment of valve diseases. Other contributing factors include enhanced surgical methods, the use of robotics in valve procedures, remote monitoring of valve patients via telemedicine, and the use of 3D printing in creating custom heart valves. Major upcoming trends during this forecast period entail advancements in techniques for valve repair and replacement, the use of artificial intelligence (AI) to detect and plan the treatment of valve diseases, the adoption of 3D printing for custom heart valve production, enhanced surgical methods, and the use of robotics in valve procedures.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cardiac-valve-global-market-report

What Are the Drivers Transforming the Cardiac Valve Market?
The escalating number of cardiovascular diseases is anticipated to enhance the expansion of the cardiac valve market. Factors such as smoking, obesity, and insufficient physical activity have led to the gradual rise in the incidence of cardiovascular diseases which strain the heart's functionality. The most extensive cause of coronary artery disease is the accumulation of fatty plaques in arteries. This steady increase in heart-related ailments has amplified the necessity for the cardiac valve, employed in treating heart valve complications. An instance from September 2023 reports by the World Health Organization, a specialized agency for health of the United Nations based in Switzerland, recorded 41 million fatalities, which constitute 74% of deaths caused by non-communicable or chronic diseases annually worldwide. There were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Hence, the upsurge in cardiovascular diseases will fuel the expansion of the cardiac valve market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7753&type=smp

What Trends Will Shape the Cardiac Valve Market Through 2029 and Beyond?
Innovations in cardiac valve technology are becoming an increasingly significant trend in the cardiac valve market. These technological advances have led to less intrusive methods of treatment for heart diseases. Prominent companies in the cardiac valve market are focusing on emerging technologies like neochordae implantation, annuloplasty ring, and robotic surgery to consolidate their market presence. Such groundbreaking technologies are instrumental in guarding patients against deadly conditions like heart strokes and cardiac arrests. For instance, Edwards, a medical tech organization based in the U.S., unveiled the Sapien 3 Ultra Resilia transcatheter heart valve equipped with anti-calcification technology, in September 2022. This technology was designed to permanently inhibit the binding of calcium in bioprosthetic valves.

Which Segments in the Cardiac Valve Market Offer the Most Profit Potential?
The cardiac valve market covered in this report is segmented -

1) By Type: Tissue Heart Valves, Transcatheter Heart Valves, Mechanical Heart Valves, Other Types
2) By Position: Aortic Valve, Mitral Valve, Other Positions
3) By Treatment: Cardiac Valve Repair, Cardiac Valve Replacement
4) By End-Users: Hospital And Clinics, Specialty Centers, Cardiac Research Institute, Other End Users

Subsegments:
1) By Tissue Heart Valves: Bioprosthetic Valves (e.g., porcine, bovine), Homograft Valves
2) By Transcatheter Heart Valves: Transcatheter Aortic Valve Implantation (TAVI) Valves, Transcatheter Mitral Valve Repair Valves
3) By Mechanical Heart Valves: Tilting Disc Valves, Bileaflet Valves, Caged Ball Valves
4) By Other Types: Conduits, Stented vs. Stentless Valves

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7753&type=smp

Which Firms Dominate the Cardiac Valve Market by Market Share and Revenue in 2025?
Major companies operating in the cardiac valve market include Abbott Laboratories, Colibri Heart Valve LLC, TTK HealthCare Limited, Artivion Inc., Edwards Lifesciences Corporation, Boston Scientific Corporation, Jenavalve Technology Inc., CryoLife Inc., Lepu Medical Technology Co. Ltd., Braile Biomedical, Sorin Group, Micro Interventional Devices Inc., Medtronic Inc., Lepu Medical Technology, Edward Lifesciences Corporation, Xeltis AG, Meril Life Sciences Pvt. Ltd., Auto Tissue Berlin GmbH, On-X Life Technologies Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc.

Which Regions Offer the Highest Growth Potential in the Cardiac Valve Market?
North America was the largest region in the cardiac valve market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac valve market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7753

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.